Sort   by:  
 Page size 
UnknownPegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study.
Not available
S-EPMC2991041 | biostudies-literature
UnknownA pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients.
Not available
S-EPMC4365273 | biostudies-literature
UnknownRituximab pharmacokinetic and pharmacokinetic-pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity.
Not available
S-EPMC9931428 | biostudies-literature
UnknownModel-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin.
Not available
S-EPMC8048880 | biostudies-literature
UnknownTissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer.
Not available
S-EPMC8632367 | biostudies-literature
UnknownExcluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity.
Not available
S-EPMC8010276 | biostudies-literature
UnknownMulticentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
Not available
S-EPMC4838684 | biostudies-literature
UnknownVirulence factors are preserved within carbapenem-resistant Acinetobacter baumannii clades.
Not available
S-EPMC12377095 | biostudies-literature
UnknownLong-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Not available
S-EPMC9164119 | biostudies-literature
UnknownAn Interscholastic Network To Generate LexA Enhancer Trap Lines in Drosophila.
Not available
S-EPMC6643891 | biostudies-literature
Sort   by:  
 Page size